Medicinal product name Talzenna
Pharmaceutical form Capsule, hard
Strength 1 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.II onk. ķīm. ter.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code L01XK04 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30: 30 × 1 kapsula (dozējamas vienības)
(1 mg)
PVC/PVDC blister    EU/1/19/1377/006  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/19/1377/006
Date of authorisation Jun 20, 2019
Marketing authorisation holder, country Pfizer Europe MA EEIG, Belgium